Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
about
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsComparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferretsA review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges aheadKey molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virusInnate immune response of human alveolar macrophages during influenza A infectionGeographic distribution and risk factors of the initial adult hospitalized cases of 2009 pandemic influenza A (H1N1) virus infection in mainland ChinaBaicalein, Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses.Influenza A virus infections in swine: pathogenesis and diagnosis.Severe respiratory insufficiency during pandemic H1N1 infection: prognostic value and therapeutic potential of pulmonary surfactant protein ASeverity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets.BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza VirusesPulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study.PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice.Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management.Hallmarks of CD4 T cell immunity against influenzaDifferences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsPreventing and treating secondary bacterial infections with antiviral agentsSwine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays.Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques.Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract.Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferretsInfluenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipientsComparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.In situ molecular identification of the influenza A (H1N1) 2009 Neuraminidase in patients with severe and fatal infections during a pandemic in Mexico CityInfluenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity.Serum metabolome and lipidome changes in adult patients with primary dengue infection.In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans.Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity.Multitask learning of signaling and regulatory networks with application to studying human response to fluToll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenzaProteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels.Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibitionTowards multiscale modeling of influenza infection
P2860
Q26800158-D1172B16-3406-4668-ABBF-A08F20DD8D63Q27312721-58078DE3-898A-4D66-9E02-86470D17ECB2Q28382972-383F587C-9E17-4FE1-B657-11225AB9F585Q28388794-B9ACE316-9BCD-4829-B42E-FA74B36718D1Q28731580-7C2D46EC-6FDE-4552-BADF-31E5440023C7Q30224924-53A44114-B884-4D3A-A4C9-E3A5F91C3F61Q30352178-C4F95912-7990-4368-8B9F-125783221CEFQ30357141-926F162B-09CB-4E4A-9E82-51FF5F45FD58Q30366382-388D2347-7513-41FD-BFDF-7021B48C2A4AQ30366406-19FD632C-5336-4951-8359-E870A4FB16AFQ30373896-0311B7A9-8E4B-477C-A10E-649E93DD165FQ30375629-64676CF0-98A1-4777-A7A0-AA437CA168A3Q30379218-AEA1FDDC-AF2E-4232-AD68-B05D690AE193Q30390515-E5C82923-7474-4543-BF3B-1E921792E004Q30395091-C4EF4FDD-2A13-4FAD-A538-788DB360988AQ30395111-EB84F1DC-62F2-4605-AE73-E339647F2717Q30399578-30667631-6CB6-4146-B5E5-4AE4A5592424Q30400290-3B142E4D-4133-4768-BB0E-EEC0A43171E2Q30400403-9F7DB5F2-7F95-451A-8879-504569A1D976Q30401260-8ED54DEF-2371-4220-B4E6-5ABE9D575E89Q30402300-B5DB019B-A761-4BE9-8042-C560AD67EF0FQ30404602-1A3D0168-210E-484C-8C71-A52629BD00B5Q30407335-A8C676F3-E136-4644-A141-20ABA377EC40Q30409273-7ED62A2E-65A1-49CA-BE4C-CA3F87311FFFQ30420448-4773ED7E-116C-4974-ACEF-234E69EEA7CAQ30421902-3A9DECD2-203F-4600-AFD6-F9FA65431F63Q30421991-81FEC49A-6099-4035-8384-0D7180C73836Q30422167-B890B0F9-278C-4FFE-8039-24FE40002C16Q30426042-22645041-3840-40F6-9017-94DF708D8444Q34131746-10C7FF91-3F17-49F1-8310-FDF0B2DCA1A3Q34445640-D8A7990C-EBEF-4DA6-BB8F-7D234B9C9D04Q34965777-07FB41D6-070B-464E-83A8-BCD66D46E405Q35170879-3AC3520B-FD03-495F-AB72-49613ABD83E7Q35200858-B60EB471-47B5-46AC-ACAB-4457BB305640Q35529844-8AABEB35-81DC-4ABE-BE6C-5131DF2987D1Q35557119-2ADC75BC-3338-45C9-B7FD-C72B5DED300AQ35893651-D5A5BB2A-76D6-4C8B-ADA6-EA10EF87675DQ36770677-011DF79F-A57A-4290-9449-FD11DBDCE9B6Q36990703-4740B17B-DE38-43E0-A83A-704D02BE3461Q37136609-AC903E3E-30DD-40AD-863B-F11420D4732E
P2860
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@ast
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@en
type
label
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@ast
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@en
prefLabel
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@ast
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@en
P1476
Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
@en
P2093
Jeannette Guarner
Reynaldo Falcón-Escobedo
P304
P356
10.1016/J.ARCMED.2009.10.001
P577
2009-11-01T00:00:00Z